Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, and Lung Cancer Research Studies.
Adaptive vs. Non-Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC): Indirect Comparison of NRG-RTOG 0617 and 1106 Individual Patient Data
Hybridizing mechanistic modeling and deep learning for personalized survival prediction after immune checkpoint inhibitor immunotherapy
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7 <sup>th</sup> immunorad conference
MRI-based deep learning can discriminate between temporal lobe epilepsy, Alzheimer’s disease, and healthy controls
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial
Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
Author response: Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling
Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches
Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy
Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer
Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer
Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab
Altered cancer metabolism in mechanisms of immunotherapy resistance
Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Metformin use and improved response to therapy in esophageal adenocarcinoma